[Twelve-year experience of bioprosthesis implantation into infrainguinal arteries].
The study presents the results of 315 infrainguinal artery reconstructions with bioprostheses from bovine internal mammary artery treated with 5% solution of diepoxide (trade name "KemAngioprosthesis"). Primary patency of KemAngioprostheses was 37.5% (n=239) in above-knee and 7.4% (n=52) in below-knee femoropopliteal bypasses in 8-year period, as well as 14.9% (n=24) in femorotibial bypass in 4.5-year period. Primary patency was significantly worse in cases of poor outflow from legs, lower limb critical ischemia, in cases of "end-to-side" anastomosis type, as well as in patients with concomitant ischemic heart disease and hypertension. KemAngioprostheses demonstrated no new or unknown complications. The most common complication was thrombosis (45.1%); infections occurred in 4.1%, hemorrhage - in 1% and biodegradation manifested by aneurysms and ectasia - in 1.9% cases. Indications for KemAngioprosthesis implantations include severe, limb-threatening ischemia with unavailable autologous vein or simultaneous two-segment arterial reconstructions in grade III-IV acute or chronic ischemia. Besides, KemAngioprostheses can be successfully used in above-knee femoropopliteal reconstructions.
Barbarash
L S
LS
Research Manufacturing Task Laboratory of Reconstructive Surgery of Heart and Vessels with Clinics, Siberian Division of Russian Academy of Medical Sciences, Kemerovo, Russia.
Ivanov
S V
SV
Zhuravleva
I Iu
IIu
Anufriev
A I
AI
Kazachek
Ia V
IaV
Kudriavtseva
Iu A
IuA
Zinets
M G
MG
D000328:Adult; D000368:Aged; D001158:Arteries / Q000601:surgery*; D050197:Atherosclerosis / Q000503:physiopathology* / Q000601:surgery*; D001705:Bioprosthesis; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007511:Ischemia / Q000601:surgery; D035002:Lower Extremity / Q000098:blood supply* / Q000601:surgery*; D008297:Male; D008875:Middle Aged